Deals Of The Week: Roche/Illumina, GSK/HGSI, Sanofi/MJFF
Executive Summary
After a few months of sometimes-testy back and forth, Illumina seemingly has successfully fended off Roche’s hostile offer. But Roche is unlikely to give up on the sequencing tool maker entirely.